{"id":"W2123808042","doi":"10.1200/jco.2009.23.2595","title":"Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma","year":2010,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":514,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Genentech; Celgene; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Lomustine; Medicine; Internal medicine; Hazard ratio; Phases of clinical research; Adverse effect; Surgery; Progression-free survival; Gastroenterology; Toxicity; Chemotherapy; Confidence interval; Vincristine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001355207,0.0001487858,0.001715106,0.0001681506,0.00001893284,0.000003436247,0.0001456643,0.0001333169,0.00008291722],"category_scores_gemma":[0.0003755529,0.00006939466,0.0002622897,0.0002075902,0.0001890716,0.00003427115,0.00001383097,0.0004983855,0.000001247109],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006344011,"about_ca_system_score_gemma":0.0004542722,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007735405,"about_ca_topic_score_gemma":0.002228971,"domain_scores_codex":[0.9966312,0.0003586256,0.002299991,0.0001466307,0.0004052606,0.0001582958],"domain_scores_gemma":[0.9956399,0.001840865,0.001756781,0.000261328,0.0003340335,0.000167048],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"nonrandomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.06849018,0.4289034,0.19307,0.00002367012,0.001095193,0.004063599,0.003238849,0.00002842429,0.001102822,0.00004108944,0.0003274878,0.2996153],"study_design_scores_gemma":[0.1958366,0.4723532,0.3214146,0.00009809196,0.001294167,0.0005475095,0.002427138,0.0001089904,0.0009067525,0.00002328764,0.004915641,0.00007399305],"study_design_candidate":"nonrandomized_trial","study_design_consensus":"nonrandomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971694,0.0001369202,0.000004707913,0.001361055,0.000508784,0.0006690472,0.000005117746,0.000002276418,0.0001427345],"genre_scores_gemma":[0.9988195,0.0001324828,0.0005107909,0.00007071145,0.000437438,0.00001600786,0.00000133765,0.000008417704,0.000003281668],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2995413,"threshold_uncertainty_score":0.2829832,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0935028942315687,"score_gpt":0.4665395752541077,"score_spread":0.373036681022539,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}